Monkeypox Spreads in West, Baffling African Scientists
Scientists who have monitored numerous outbreaks of monkeypox in Africa say they are baffled by the disease’s recent spread in Europe and North America. Cases of the smallpox-related disease have previously been seen only among people with links to central and West Africa. But in the past week, Britain, Spain, Portugal, Italy, U.S., Sweden and Canada all reported infections, mostly in young men who hadn’t previously traveled to Africa. France, Germany, Belgium and Australia confirmed their first cases of monkeypox on Friday. “I’m stunned by this. Every day I wake up and there are more countries infe...
Source: TIME: Health - May 20, 2022 Category: Consumer Health News Authors: Maria Cheng / AP Tags: Uncategorized Africa Disease healthscienceclimate wire Source Type: news

COVID-19: background information, UKHSA (updated 17th May 2022)
Information on COVID-19 including epidemiology, virology and clinical features. 17 May 2022Updated epidemiology, virology, transmission and clinical features sections. Added section on vaccination. 6 October 2021Update to guidance in line with latest data and available evidence. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 17, 2022 Category: Consumer Health News Source Type: news

Mysterious hepatitis outbreak in children will continue 'throughout the summer', expert warns
EXCLUSIVE: Dr Matthew Binnicker, the director of clinical virology at the Mayo Clinic in Minnesota, warned cases will continue to crop up throughout the summer months. (Source: the Mail online | Health)
Source: the Mail online | Health - May 13, 2022 Category: Consumer Health News Source Type: news

HCV-Related Depression, Anxiety, and Cognitive Improvements HCV-Related Depression, Anxiety, and Cognitive Improvements
Chronic HCV patients may realize neuropsychiatric and cognitive improvements after achieving sustained virological response with direct-acting antiviral agents.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 9, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Covid symptoms: Stealth variant cases rising globally – symptoms of new variant to spot
COVID symptoms are known to change somewhat depending on the variant circulating, says many leading virologists. Cases of the Stealth variant have been on the rise recently with four main symptoms to spot potentially indicating an infection from the new variant. (Source: Daily Express - Health)
Source: Daily Express - Health - May 3, 2022 Category: Consumer Health News Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good sales growth in the first quarter of 2022
Basel, 25 April 2022Group sales increase 11%1 at constant exchange rates (CER) and 10% in Swiss francsPharmaceuticals Divisionsales up 6%; continued strong sales of new medicines for severe diseases. Impact of biosimilars decreases as expected.Diagnostics Divisionsales grow 24% due to good momentum in base business and continued high demand for COVID-19 tests. After a strong first quarter, significant decline in COVID-19-related testing expected.Highlights in the first quarter:FDA approval of Vabysmo (severe eye diseases); CHMP recommends EU approval of Polivy combination (aggressive form of blood cancer), Tecentriq (early...
Source: Roche Media News - April 25, 2022 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good sales growth in the first quarter of 2022
Group sales increase 11%1 at constant exchange rates (CER) and 10% in Swiss francsPharmaceuticals Divisionsales up 6%; continued strong sales of new medicines for severe diseases. Impact of biosimilars decreases as expected.Diagnostics Divisionsales grow 24% due to good momentum in base business and continued high demand for COVID-19 tests. After a strong first quarter, significant decline in COVID-19-related testing expected.Highlights in the first quarter:FDA approval of Vabysmo (severe eye diseases); CHMP recommends EU approval of Polivy combination (aggressive form of blood cancer), Tecentriq (early-stage non-small cel...
Source: Roche Investor Update - April 25, 2022 Category: Pharmaceuticals Source Type: news

Covid-19 infections spike: Experts agree on masking up and ventilation
"It's important to be sensible and understand the risk factors -- if you're indoors, it's better to wear a mask. If it's crowded, even more so. Without worrying about a particular variant, a good mask, when worn properly, will protect you," says virologist Dr Shahid Jameel, research fellow at Green Templeton College, Oxford. (Source: The Economic Times)
Source: The Economic Times - April 24, 2022 Category: Consumer Health News Source Type: news

COVID-19 Could Be Surging in the U.S. Right Now and We Might Not Even Know It
The rise of Covid cases in some regions of the U.S., just as testing efforts wane, has raised the specter that the next major wave of the virus may be difficult to detect. In fact, the country could be in the midst of a surge right now and we might not even know it. Testing and viral sequencing are critical to responding quickly to new outbreaks of Covid. And yet, as the country tries to move on from the pandemic, demand for lab-based testing has declined and federal funding priorities have shifted. The change has forced some testing centers to shutter while others have hiked up prices in response to the end of government-...
Source: TIME: Health - April 11, 2022 Category: Consumer Health News Authors: MADISON MULLER / BLOOMBERG Tags: Uncategorized bloomberg wire COVID-19 healthscienceclimate Source Type: news

Viral Suppression After Transition to DTG-Based ART Viral Suppression After Transition to DTG-Based ART
What have we learned about the virological effectiveness of transitioning from NNRTI-based regimens to DTG-containing ART?HIV Medicine (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - March 31, 2022 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Why Researchers Are Still Testing Wild Animals for COVID-19
(Grand Portage, Minn.) — To administer this COVID test, Todd Kautz had to lay on his belly in the snow and worm his upper body into the narrow den of a hibernating black bear. Training a light on its snout, Kautz carefully slipped a long cotton swab into the bear’s nostrils five times. For postdoctoral researcher Kautz and a team of other wildlife experts, tracking the coronavirus means freezing temperatures, icy roads, trudging through deep snow and getting uncomfortably close to potentially dangerous wildlife. They’re testing bears, moose, deer and wolves on a Native American reservation in the remote n...
Source: TIME: Health - March 30, 2022 Category: Consumer Health News Authors: Laura Ungar / AP Tags: Uncategorized COVID-19 healthscienceclimate News Desk wire Source Type: news

U.S. FDA Approves CABENUVA (cabotegravir and rilpivirine) for Adolescents, Expanding the Indication of the First and Only Complete Long-Acting Injectable HIV Regimen
TITUSVILLE, N.J., March 29, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA (cabotegravir and rilpivirine) for the treatment of HIV-1 in virologically suppressed adolescents (HIV-1 RNA less than 50 copies per milliliter [c/mL]) who are 12 years of age or older, weigh at least 35 kg and are on a stable antiretroviral regimen, with no history of treatment failure, nor known or suspected resistance to either cabotegravir or rilpivirine.1,2 Co-developed as part of a collaboration with ViiV Healthcare, CABENUVA is the first ...
Source: Johnson and Johnson - March 30, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Virologically Suppressed Adolescents Living with HIV Who Are 12 Years of Age or Older and Weigh at Least 35 kg
Research Triangle Park, NC, March 29, 2022– ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi B.V. as shareholders, today announced that the US... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 29, 2022 Category: Drugs & Pharmacology Source Type: news

Why the UK can ’t rely on boosters to get through each new wave of Covid | Danny Altmann
The evidence suggests performance could be less predictable and effective in the future – though there are promising developmentsDanny Altmann is a professor of immunology at Imperial College LondonThis time in 2020, we watched with horror as the realities of the pandemic and its death toll unfurled. Most hardly dared imagine thateffective vaccines might appear in a fraction of the time taken for previous efforts, effectively stemming the pandemic tide.But despite the success of the vaccines in greatly reducing the odds of hospitalisation or death, viral evolution had plenty more to throw at us. The onslaught of highlyim...
Source: Guardian Unlimited Science - March 28, 2022 Category: Science Authors: Danny Altmann Tags: Immunology Vaccines and immunisation Coronavirus UK news Health Science Society Source Type: news

'One in 15' infected with new Covid variant, warns Dr Chris
THERE is widespread belief that the coronavirus is loosening its grip, but current data suggests otherwise. Relaxed Covid measures and the higher transmissibility of the Omicron variant could be driving a surge in Covid infections across the country, warned virologist doctor Chris on BBC Breakfast today. (Source: Daily Express - Health)
Source: Daily Express - Health - March 26, 2022 Category: Consumer Health News Source Type: news